<DOC>
	<DOCNO>NCT01954914</DOCNO>
	<brief_summary>With standard mobilization regimen use G-CSF , approximately 5 % allogeneic donor mobilize enough CD34+ cell reach optimal dose transplantation therefore call `` poor mobilizers '' . A generally accept optimum CD34+ PBSC dose allogeneic transplantation &gt; 4.5 x 106/kg body weight recipient . The minimum total CD34+ PBSC dose certainly amount 2 x 106/kg body weight recipient.The objective trial ass efficacy single dose Plerixafor salvage procedure allogeneic stem cell donor poor CD34+ cell yield first day peripheral blood stem cell collection .</brief_summary>
	<brief_title>Plerixafor Salvage Regimen Mobilize Allogeneic Stem Cells Healthy Volunteers</brief_title>
	<detailed_description>In trial administration single dose Plerixafor 240 µg/kg body weight donor SC even 10 PM frustraneous stem cell apheresis day 1 provide . The apheresis day 2 perform accord standard recommendation .</detailed_description>
	<mesh_term>JM 3100</mesh_term>
	<criteria>Donor age 18 year 75 year Eligibility donor allogeneic PBSC donation accord German Guidelines ( Richtlinien Hämotherapie Bundesärztekammer 2005 ) precede application GCSF The donor understood sign donor information . Written inform consent obtain . Donation le 2.0 x 106 CD34 cells/kg recipient body weight one apheresis follow five day stemcell mobilization Lenograstim 7.5 10 µg/kg donor body weight First leukapheresis accord standard recommendation process 3 x donor 's blood volume ± 10 % use either follow three device : Cobe Spectra ( Terumo BCT ) Spectra Optia ( Terumo BCT ) Fresenius COM.TEC Pain discomfort leave upper square abdomen physical examination immediately prior study inclusion spontaneous complaint abdominal discomfort without ultrasound investigation rule splenomegaly . Palpitations thoracic discomfort absence ECG show normal result Platelet count &lt; 80 x 109/l Serum creatinine &gt; 80 µmol/l female donor &gt; 106 µmol/l male donor . If serum creatinine elevate estimate creatinine clearance &gt; 50 ml/min . Estimation Modification Diet Renal Disease equation predict GFR ( ml/min/1.73m2 ) = 186 x ( Serum Creatinine mg/dL ) 1.154 x ( age year ) 0.203 x ( 0.742 patient female ) x ( 1.212 patient black ) GFR ( ml/min/1.73m2 ) = 186 x 176 ( Serum Creatinine µmol/l ) 1.154 x ( age year ) 0.203 x ( 0.742 patient female ) x ( 1.212 patient black ) Contraindications second leukapheresis , severe side effect 1st leukapheresis ( intolerable pain , severe circulatory disorder , severe citrate intolerance ) Missing write approval transplant center transplantation Plerixaformobilized graft consider Treatment know nonmarketed drug substance experimental therapy within 4 week prior enrolment participation interventional clinical study Any significant concurrent disease , illness , psychiatric disorder would compromise donor safety compliance , interfere consent , study participation , follow , interpretation study result Female donor childbearing potential unable unwilling use adequate contraception method three month administration study drug . Adequate method contraception female donor sexual abstinence , use condom partner , vasectomy partner hormonal contraception . Male donor unable unwilling use adequate contraception method one month administration study drug . Adequate method contraception male sexual abstinence use condom . Known intolerance Plerixafor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Plerixafor</keyword>
	<keyword>donor</keyword>
	<keyword>allogeneic peripheral stam cell donation</keyword>
	<keyword>PBSC</keyword>
	<keyword>poor donor</keyword>
</DOC>